These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 11940656)
1. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Sang N; Fang J; Srinivas V; Leshchinsky I; Caro J Mol Cell Biol; 2002 May; 22(9):2984-92. PubMed ID: 11940656 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Tanimoto K; Makino Y; Pereira T; Poellinger L EMBO J; 2000 Aug; 19(16):4298-309. PubMed ID: 10944113 [TBL] [Abstract][Full Text] [Related]
3. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592 [TBL] [Abstract][Full Text] [Related]
5. Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product. Pereira T; Zheng X; Ruas JL; Tanimoto K; Poellinger L J Biol Chem; 2003 Feb; 278(9):6816-23. PubMed ID: 12468553 [TBL] [Abstract][Full Text] [Related]
6. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Jaakkola P; Mole DR; Tian YM; Wilson MI; Gielbert J; Gaskell SJ; von Kriegsheim A; Hebestreit HF; Mukherji M; Schofield CJ; Maxwell PH; Pugh CW; Ratcliffe PJ Science; 2001 Apr; 292(5516):468-72. PubMed ID: 11292861 [TBL] [Abstract][Full Text] [Related]
9. The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Pugh CW; Ratcliffe PJ Semin Cancer Biol; 2003 Feb; 13(1):83-9. PubMed ID: 12507560 [TBL] [Abstract][Full Text] [Related]
10. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Masson N; Willam C; Maxwell PH; Pugh CW; Ratcliffe PJ EMBO J; 2001 Sep; 20(18):5197-206. PubMed ID: 11566883 [TBL] [Abstract][Full Text] [Related]
11. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. Yuan Y; Hilliard G; Ferguson T; Millhorn DE J Biol Chem; 2003 May; 278(18):15911-6. PubMed ID: 12606543 [TBL] [Abstract][Full Text] [Related]
12. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Epstein AC; Gleadle JM; McNeill LA; Hewitson KS; O'Rourke J; Mole DR; Mukherji M; Metzen E; Wilson MI; Dhanda A; Tian YM; Masson N; Hamilton DL; Jaakkola P; Barstead R; Hodgkin J; Maxwell PH; Pugh CW; Schofield CJ; Ratcliffe PJ Cell; 2001 Oct; 107(1):43-54. PubMed ID: 11595184 [TBL] [Abstract][Full Text] [Related]
13. The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism. Tang TT; Lasky LA J Biol Chem; 2003 Aug; 278(32):30125-35. PubMed ID: 12761217 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
15. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Groulx I; Lee S Mol Cell Biol; 2002 Aug; 22(15):5319-36. PubMed ID: 12101228 [TBL] [Abstract][Full Text] [Related]
16. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. Salnikow K; Donald SP; Bruick RK; Zhitkovich A; Phang JM; Kasprzak KS J Biol Chem; 2004 Sep; 279(39):40337-44. PubMed ID: 15271983 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex. Miller F; Kentsis A; Osman R; Pan ZQ J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064 [TBL] [Abstract][Full Text] [Related]